Macrophage Infiltration of Breast Tumours: a Prospective Study

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1977 Jun 1

PMID 874114

Citations 26

Authors

I LAUDER

W Aherne

J Stewart

R Sainsbury

Affiliations

Soon will be listed here.

Abstract

In 50 cases of infiltrating breast cancer investigated in a prospective study the number of macrophages within each tumour was assessed. The macrophages were identified by their cytoplasmic acid phosphatase activity. The number of lymphocytes and plasma cells within the tumours were graded by a scoring technique. Significantly fewer cases with metastases were found among those with high macrophage and plasma cell scores. There was no correlation between lymphoreticular infiltration and the degree of tumour differentiation, but in cases without metastases the lymphoreticular infiltration between tumour cells was nearly always only slight when the macrophage score was low.

Citing Articles

Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies.

Hussain K, Cragg M, Beers S Cancers (Basel). 2021; 13(19).

PMID: 34638388 PMC: 8507767. DOI: 10.3390/cancers13194904.

The Impact of the Cancer Microenvironment on Macrophage Phenotypes.

Ham S, Lima L, Lek E, Moller A Front Immunol. 2020; 11:1308.

PMID: 32655574 PMC: 7324670. DOI: 10.3389/fimmu.2020.01308.

Cytokine pattern of the breast tumor supernatant.

Autenshlyus A, Kunts T, Karpukhina K, Mikhaylova E, Varaksin N, Marinkin I Dokl Biol Sci. 2016; 470(1):247-248.

PMID: 27822759 DOI: 10.1134/S0012496616050057.

Clinical significance of macrophage heterogeneity in human malignant tumors.

Komohara Y, Jinushi M, Takeya M Cancer Sci. 2013; 105(1):1-8.

PMID: 24168081 PMC: 4317877. DOI: 10.1111/cas.12314.

Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells.

Szabo K, Singh G Breast Cancer Res. 2005; 7(5):R661-8.

PMID: 16168111 PMC: 1242127. DOI: 10.1186/bcr1261.

References

White W . LATE RESULTS OF OPERATION FOR CARCINOMA OF THE BREAST. Ann Surg. 1927; 86(5):695-701. PMC: 1399437. View

Monis B, Weinberg T . Cytochemical study of esterase activity of human neoplasms and stromal macrophages. Cancer. 1961; 14:369-77. DOI: 10.1002/1097-0142(196103/04)14:2<369::aid-cncr2820140217>3.0.co;2-x. View

Berg J . Inflammation and prognosis in breast cancer; a search for host resistance. Cancer. 1959; 12(4):714-20. DOI: 10.1002/1097-0142(195907/08)12:4<714::aid-cncr2820120414>3.0.co;2-b. View

BURSTONE M . Histochemical demonstration of acid phosphatases with naphthol AS-phosphates. J Natl Cancer Inst. 1958; 21(3):523-39. View

Black M, OPLER S, SPEER F . Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. Surg Gynecol Obstet. 1955; 100(5):543-51. View

Champion H, Wallace I, Prescott R . Histology in breast cancer prognosis. Br J Cancer. 1972; 26(2):129-38. PMC: 2008433. DOI: 10.1038/bjc.1972.19. View

Krahenbuhl J, Lambert Jr L . Cytokinetic studies of the effects of activated macrophages on tumor target cells. J Natl Cancer Inst. 1975; 54(6):1433-7. DOI: 10.1093/jnci/54.6.1433. View

MORRISON A, Black M, Lowe C, MacMahon B, Yuasa S . Some international differences in histology and survival in breast cancer. Int J Cancer. 1973; 11(2):261-7. DOI: 10.1002/ijc.2910110203. View

GOLDENBERG V, Goldenberg N, SOMMERS S . Comparative ultrastructure of atypical ductal hyperplasia, intraductal carcinoma, and infiltrating ductal carcinoma of the breast. Cancer. 1969; 24(6):1152-69. DOI: 10.1002/1097-0142(196912)24:6<1152::aid-cncr2820240614>3.0.co;2-5. View

10.

Underwood J . Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer. 1974; 30(6):538-48. PMC: 2009334. DOI: 10.1038/bjc.1974.233. View

11.

Underwood J, Carr I . The ultrastructure of the lymphoreticular cells in non-lymphoid human neoplasms. Virchows Arch B Cell Pathol. 1972; 12(1):39-50. DOI: 10.1007/BF02893984. View

12.

Eccles S, Alexander P . Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature. 1974; 250(5468):667-9. DOI: 10.1038/250667a0. View

13.

Evans R, Alexander P . Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972; 236(5343):168-70. DOI: 10.1038/236168a0. View

14.

Roberts M, Bass E, Wallace I, Stevenson A . Local immunoglobulin production in breast cancer. Br J Cancer. 1973; 27(4):269-75. PMC: 2008783. DOI: 10.1038/bjc.1973.33. View

15.

Evans R . Macrophages in syngeneic animal tumours. Transplantation. 1972; 14(4):468-73. DOI: 10.1097/00007890-197210000-00011. View

16.

CURRIE G, Basham C . Activated macrophages release a factor which lyses malignant cells but not normal cells. J Exp Med. 1975; 142(6):1600-5. PMC: 2190066. DOI: 10.1084/jem.142.6.1600. View

17.

Lejeune F . Role of macrophages in immunity, with special reference to tumour immunology. A review. Biomedicine. 1975; 22(1):25-34. View

18.

Koppelmann L, Moore T, Lemmi C, PORTER D . Accumulation of mononuclear cells in tumors with growth slowing and elevation in host splenic histidine decarboxylase activity following repeated tumor injections with bradykinin. Surgery. 1975; 78(2):181-9. View

19.

Evans R, Alexander P . Cooperation of immune lymphoid cells with macrophages in tumour immunity. Nature. 1970; 228(5272):620-2. DOI: 10.1038/228620a0. View

20.

HAMLIN I . Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer. 1968; 22(3):383-401. PMC: 2008376. DOI: 10.1038/bjc.1968.47. View